Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia)

Critical Reviews in Oral Biology and Medicine

Volumn 14, Issue 4, 2003, Pages 253-267

  Sitheeque, M A M ^a   Samaranayake, L P ^b  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Candida; Hyperplastic candidosis candidiasis; Review

Indexed keywords

ANTIFUNGAL AGENT; BETA CAROTENE; BLEOMYCIN; BLOOD GROUP ANTIGEN; FLUCONAZOLE; FORMALDEHYDE; METHAMPHETAMINE; NITROSAMINE; POLYENE; PROTEIN P53; RETINOID DERIVATIVE; RETINOL; TRIAZOLE;

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CANDIDA ALBICANS; CARCINOGENESIS; CELL INFILTRATION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLAMMATORY CELL; LEUKOPLAKIA; LOW LEVEL LASER THERAPY; MOUTH CARCINOMA; NUTRITIONAL DEFICIENCY; ORAL BIOPSY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SILVER STAINING; SMOKING; THRUSH; VITAMIN DEFICIENCY; BLOOD; CANDIDA; DISEASE PREDISPOSITION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; CHRONIC DISEASE; DIABETES COMPLICATIONS; DISEASE SUSCEPTIBILITY; HUMANS; HYPERPLASIA; LEUKOPLAKIA, ORAL;

EID: 0041731706     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130301400403     Document Type: Review

References (175)

1. Andriole VT, Hasenclever HF (1962). Factors influencing experimental candidiasis in mice. I. Alloxan diabetes. Yale J Biol Med 35:96-142.
2. Arendorf TM (1984). Factors affecting oral candidal colonisation in health and disease. Br Dent J 147:267-272.
3. Arendorf TM, Walker DM (1979). Oral candidal populations in health and disease. Br Dent J 147:267-272.
4. Arendorf TM, Walker DM (1980). The prevalence and distribution of Candida albicans in man. Arch Oral Biol 15:1-10.
5. Arendorf TM, Walker DM, Kingdom RJ, Roll JRS, Newcombe RG (1983). Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J 155:340-343.
6. Axéll T (1976). A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Dinamica Suppl 36:1-103.
7. Bánóczy J (1977). Follow-up studies in oral leukoplakia. J Maxillofac Surg 5:69-75.
8. Bánóczy J (1982). Oral leukoplakia. The Hague: Martinus Nijhoff, pp. 53-59.
9. Bánóczy J, Gintner Z, Dombi C (2001). Tobacco use and oral leukoplakia. J Dent Educ 65:322-327.
10. Barrett AW, Kingsmill VJ, Speight PM (1998). The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis 4:26-31.
11. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA (2001). PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol 39:4066-4075.
12. Barua D, Pagvio AS (1977). ABO blood groups and cholera. Ann Human Biol 4:489-492.
13. Bastiaan RJ, Reade RC (1982). The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses. Oral Surg Oral Med Oral Pathol 53:148-151.
14. Beasley JD III (1969). Smoking and oral moniliasis. J Oral Med 24:83-86.
15. Bennet KR, Reade PC (1982). Salivary immunoglobulin A levels in tobacco smokers and patients with minor aphthous ulceration. Oral Surg Oral Med Oral Pathol 53:461-465.
16. Bird GW, Tovey GH (1982). The blood groups. In: Blood and its disorders. Hardisty RM, Weatherall DJ, editors. Oxford: Blackwell Scientific, pp. 1339-1431.
17. Borg M, Ruechel R (1988). Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 56:626-631.
18. Borg M, Kirk D, Baumgarten H, Ruechel R (1984). A colorimetric assay for the assessment of cytotoxicity of yeasts. Sabouraudia 22:357-367.
19. Bruszt Von P (1962). Stomato-onkologische Reihenuntersuchungen in sieben Gemeinden. Sud Schweiz Monats Zahnheilkund 72:758-766.
20. Budtz-Jørgensen E (1973). Immune response to C. albicans in monkeys with experimental candidiasis in the palate. Scand J Dent Res 81:360-371.
21. Budtz-Jørgensen E (1990). Candida-associated denture stomatitis and angular cheilitis. In: Oral candidosis. Chap. 9. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
22. Burford-Mason AP, Weber JCP, Willoughby JMJ (1988). Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. J Med Vet Mycol 26:49-56.
23. Burkhardt A, Seifert G (1977). Morphologische Klassifikation den oralen leukoplakien. Dtzch Med Wochenschr 102:223-227.
24. Cawson RA (1966a). Chronic oral candidiasis and leukoplakia. Oral Surg Oral Med Oral Pathol 22:582-591.
25. Cawson RA (1966b). Chronic oral candidosis, denture stomatitis and chronic hyperplastic candidosis. In: Symposium on Candida infections. Winner HI, Hurley R, editors. London: Livingstone, pp. 138-53.
26. Cawson RA (1973). Induction of epithelial hyperplasia by Candida albicans. Br J Dermatol 89:497-503.
27. Cawson RA, Binnie WH (1980). Candidal leukoplakia and carcinoma. A possible relationship. In: Oral premalignancy. Mackenzie IA, Dabelsteen E, Squier C, editors. Iowa City: University of Iowa Press, pp. 59-66.
28. Cawson RA, Lehner T (1968). Chronic hyperplastic candidosis-candidal leukoplakia. Br J Dermatol 80:9-16.
29. Cernea P, Crepy C, Kuffer R, Mascaro JM, Badillet G, Marie JL (1965). Aspects peu connus de candidosis buccales. Les Candidases à foyers multiples de la cavité buccale. Rev Stomatol (Paris) 66:103-138,
30. Challacombe SJ (1986). Haematological abnormalities in oral lichen planus, candidiasis, leukoplakia and non-specific stomatitis. Int J Oral Maxillofac Surg 15:72-80.
31. Challacombe S (1990). Immunology of oral candidosis. In: Oral candidosis. Chap. 6. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
32. Challacombe SJ (1994). Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 78:202-210.
33. Coleman G, Beighton D, Chalk A, Wake S (1976). Cigarette smoking and the microbial flora of the mouth. Aust Dent J 21:111-118.
34. Critchley IA, Douglas LJ (1987a). Isolation and partial characterization of an adhesin from Candida albicans. J Gen Microbiol 133:629-636.
35. Critchley IA, Douglas LJ (1987b). Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol 133:637-643.
36. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM (1996). p53 protein expression in malignant, premalignant and nonmalignant lesions of the lip. J Clin Pathol 49:648-653.
37. Cruz-Coke R, Parades L, Montenegro A (1965). Blood groups and urinary micro-organisms. J Med Genet 2:185-188.
38. Daftary DK, Mehta FS, Gupta PC, Pindborg JJ (1972). The presence of Candida in 723 oral leukoplakias among Indian villagers. Scand J Dent Res 80:75-79.
39. Daniels TE, Schwartz O, Larsen V, Dabelsteen E, Pindborg J (1985). Langerhans cells in candidal leukoplakia. J Oral Pathol 14:733-739.
40. Darwazeh A, Lamey P-J, Samaranayake LP, MacFarlane TW (1990). The relationship between oral yeast colonization and in vitro adhesion of Candida to buccal cells of diabetics. J Med Microbiol 33:43-49.
41. Dasanayake RS, Samaranayake LP (2003). Amplification based nucleic acid scanning techniques to assess genetic polymorphism in Candida: a review. CRC Crit Rev Microbiol 29:1-24.
42. De Greciansky O, Leclerc R, Delaporte J, Gouin De Roumilly P (1957). Influence des carences (deficiencies) sur l'infection experimentale a Candida albicans sur rat blanc. Sem hôpitaux de Paris 33:273-276.
43. Di Menna ME (1952). Natural occurrence of rough variant of a yeast. Nature 196:550-551.
44. Ellepola ANB, Samaranayake LP (2001). Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis 7:211-216.
45. Epstein JB, Kimura LH, Menard TW, Truelove EL, Pearsall NN (1982). Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 27:469-474.
46. Eyre J, Nally FF (1971). Oral candidosis and carcinoma. Br J Dermatol 85:73-75.
47. Farman AG (1976). Atrophic lesions of the tongue. A prevalence study among 175 diabetic patients. J Oral Pathol 5:225-264.
48. Field EA, Field JK, Martin MV (1989). Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol 27:277-294.
49. Fisher BM, Lamey P-J, Samaranayake LP, MacFarlane TW, Frier BM (1987). Carriage of Candida species in the oral cavity in diabetic patients: relationship of glycaemic control. J Oral Pathol 16:282-284.
50. Franklin CD, Martin MV (1986). The effect of Candida albicans on turpentine induced hyperplasia of hamster cheek pouch. J Med Vet Mycol 24:281-287.
51. Gao Y (1996). Cell proliferation in oral candidal leukoplakia. Zhonghua Kou Qiang Yi Xue Za Zhi 28:35-37, 64 (in Chinese).
52. Gergely L, Uri J (1966). Day-by-day variation in the mycotic flora of the mouth. Arch Oral Biol 11:15-19.
53. Ghannoum MA (2000). Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122-143.
54. Hoffmann D, Sanghvi LD, Wynder EL (1974). Comparative chemical analysis of Indian bidi and American cigarette smoke. Int J Cancer 14:49-53.
55. Holmstrup P, Besserman M (1983). Clinical, therapeutic and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol 56:388-395.
56. Hornstein PO, Grabel R, Schuner E, Shell H (1979). Oral Candida - Besiedlung bei leukoplakien und Karzinomen der Mundhole. Deutsche Medizinische Wochenschrift 104:1033-1036.
57. Hoyer LL (2001). The ALS gene family of Candida albicans. Trends Microbiol 9:176-180.
58. Hurley R (1966). Experimental infection with Candida albicans in modified hosts. J Pathol Bacteriol 92:57-67.
59. Jacobs A (1961). Iron containing enzymes in the buccal epithelium (letter). Lancet ii:1331.
60. Jenkins WMM, MacFarlane TW, Ferguson MM, Mason DK (1977). Nutritional deficiency in oral candidosis. Int J Oral Surg 6:204-210.
61. Jennings KJ, MacDonald DG (1990). Histological, microbiological and haematological investigations in denture induced stomatitis. J Dentistry 5:34-37.
62. Jepsen A, Winther JE (1965). Mycotic infection in oral leukoplakia. Acta Odontol Scand 23:239-256.
63. Jepsen A, Arenholdt-Bindslev D, Krogh P, Holmstrup P (1988). In vitro effect of Candida related nitrosamines (abstract). J Dent Res 67:752.
64. Joynson DHM, Walker DM, Jacobs A, Dolby AE (1972). Defects of cell mediated immunity in patients with iron deficient anaemia. Lancet ii:1058-1059.
65. Kantarcioglu AS, Yucel A (2002). Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45:160-165.
66. Kennedy MJ (1988). Adhesion and association mechanisms of Candida albicans. Curr Top Med Mycol 2:73-169.
67. Kennedy MJ, Sandin RL (1988). Influence of growth conditions on Candida albicans adhesion, hydrophobicity and cell wall structure. J Med Vet Mycol 26:79-92.
68. Kenney EB, Kraal JH, Saxe SR, Jones J (1977). The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodontal Res 12:227-234.
69. Kimura LH, Pearsall NN (1978). Adherence of Candida albicans to human buccal epithelial cells. Infect Immun 21:64-68.
70. Kinane DF, Blackwell CC, Winstanley FP, Weir DM (1983). Blood group secretor status and susceptibility to infection by Neisseria gonorrhoeae. Br J Venereal Dis 59:44-46.
71. Knight L, Fletcher J (1971). Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellius. J Infect Dis 123:371-377.
72. Krogh P, Hald B, Holmstrup P (1987a). Possible mycologic aetiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 8:1543-1548.
73. Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ (1987b). Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 63:48-54.
74. Kugelman TP, Cripps DJ, Harrell ER Jr (1963). Candida granuloma with epidermophytosis: report of a case and review of the literature. Arch Dermatol 88:150-155.
75. Kumar S, Joshi KR, Mathur JS, Mathur DR (1980). A study of germ tube formation by Candida albicans in biological fluids of diabetic patients. Indian J Pathol Microbiol 23:45-49.
76. Kumar S, Mathur JS, Chaudhary SK, Chawla SN (1982). A comparative study of germ tube formation by Candida albicans in serum and saliva of healthy individuals and diabetic patients. J Postgrad Med 28:84-87.
77. Lacey CJ, Dutton S, Smith RA, Walmsley RM, Wilkinson BM, Evans EG, et al. (1995). The oncogenic potential of Candida in the female genital tract. Int J Gynecol Cancer 5:8-14.
78. Lamey PJ, Lewis MA, MacDonald DG (1989). Treatment of candidal leukoplakia with fluconazole. Br Dent J 166:296-298.
79. Lamey PJ, Darwazeh AM, Muirhead J, Rennie JS, Samaranayake LP, MacFarlane TW (1991). Chronic hyperplastic candidosis and secretor status. J Oral Pathol Med 20:64-67.
80. Lamey PJ, Douglas PS, Napier SS (1994). Secretor status and oral cancer. Br J Oral Maxillofac Surg 32:214-217.
81. Lehner T (1964). Chronic candidiasis. Br Dent J 116:539-545.
82. Lehner T (1966). Classification and clinico-pathological features of Candida infections in the mouth. In: Symposium on Candida infections. Winner HI, Hurley R, editors. Edinburgh: Livingstone Ltd., pp. 119-136.
83. Lehner T (1967). Oral candidosis. Dent Pract 17:209-216.
84. Lehner T (1971). Quantitative assessment of lymphocytes and plasma cells in leukoplakia, candidiasis and lichen planus. J Dent Res 50:1661-1665.
85. Lehner T, Buckley HR, Murray IG (1972a). The relationship between fluorescent, agglutinating, and precipitating antibodies to Candida albicans and their immunoglobulin classes. J Clin Pathol 25:344-348.
86. Lehner T, Wilton JMA, Ivanyi L (1972b). Immuno-deficiencies in chronic mucocutaneous candidosis. Immunology 22:755-787.
87. Lipperheide V, Quindos G, Jimenez Y, Ponton J, Bagan-Sebastian JV, Aguirre JM (1996). Candida biotypes in patients with oral leukoplakia and lichen planus. Mycopathologia 134:75-82.
88. Lischewski A, Harmsen D, Wilms K, Baier G, Gunzer U, Klinker H, et al. (1999). Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique. Mycoses 42:371-383.
89. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A (2001). Interventions for treating oral leukoplakia (Cochrane review). Cochrane Database Syst Rev Vol 4, CD001829.
90. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A (2002). Systematic review of randomized trials for the treatment of oral leukoplakia. J Dent Educ 66:896-902.
91. MacFarlane TW, Mason DK (1973). Changes in the oral flora in Sjögren's syndrome. J Clin Pathol 27:416-421.
92. Marrie TJ, Costerton JU (1981). The ultrastructure of Candida albicans infections. Can J Microbiol 27:1156-1164.
93. Martin MV, Al-Tikriti V, Bramley P (1981). Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer. J Med Microbiol 14:457-467.
94. May SJ, Blackwell CC, Weir DM (1986). Nonsecretion of blood group antigens and susceptibility to Candida albicans: the role of Lewis blood group antigens (abstract). J Dent Res 65:503.
95. McCourtie J, Douglas LJ (1981). Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun 32:1236-1241.
96. McCullough M, Jaber M, Barrett AW, Bain L, Speight P, Porter SR (2002). Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol 38:391-393.
97. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK (1969). Epidemological and histological study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 24:832-849.
98. Mehta FS, Gupta PC, Daftary DK, Pindborg JJ, Choksi SK (1972). An epidemiologic study of oral cancer and precancerous conditions among 101,761 villagers in Maharashtra. Int J Cancer 10:134-141.
99. Montes LF, Krumdiech C, Cornwell PE (1973). Hypovitaminosis A in patients with mucocutaneous candidiasis. J Infect Dis 128:227-230.
100. Mosadomi A, Shklar G, Loftus ER, Chauncey HH (1978). Effects of tobacco smoking and age on the keratinization of palatal mucosa: a cytologic study. Oral Surg Oral Med Oral Pathol 46:413-417.
101. Mourant AK, Kopee AC, Domaniewski-Sobezak K (1978). Blood groups and disease: a study of associations of diseases with blood groups and other polymorphisms. Oxford: Oxford University Press.
102. Nagai Y, Takeshita N, Saku T (1992). Histopathologic and ultrastructural studies of oral mucosa with Candida infection. J Oral Pathol Med 21:171-175.
103. Nater JP, Zecha JJ, Heida F (1977). Floride orale papillomatose oder "speckled Leukoplakie". Hautarzt 28:18-22.
104. Negi M, Tsuboi R, Matsui T, Ogawa H (1984). Isolation and characterization of proteinase from Candida albicans: substrate specificity. J Invest Dermatol 83:32-36.
105. O'Grady JF, Reade PC (1992). Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis 13:786-786.
106. Odds FC (1988). Candida and candidosis. 2nd ed. London: Baillière Tindall.
107. Oliver DE, Shillitoe EJ (1984). Effects of smoking on the prevalence and intraoral distribution of Candida albicans. J Oral Pathol 13:265-270.
108. Partridge BM, Athar MA, Winner HI (1971). Chick embryo and inoculation as a pathogenicity test for Candida species. J Clin Pathol 24:645-648.
109. Pindborg JJ (1980). Oral cancer and precancer. Bristol: Wright.
110. Pindborg JJ, Renstrup G, Poulsen HF, Silverman S (1963). Studies in oral leukoplakia. V. Clinical and histological signs of malignancy. Acta Odontol Scand 21:407-414.
111. Pindborg JJ, Kjaer J, Gupta PC (1967). Studies in oral leukoplakia. Prevalence of leukoplakia among 10,000 persons in Lucknow, India, with special reference to use of tobacco and betel nut. Bull WHO 37:109-116.
112. Pindborg JJ, Reibel J, Roed-Petersen B, Mehta FS (1980). Tobacco-induced changes in oral leukoplakic epithelium. Cancer 45:2330-2336.
113. Pugh D, Cawson RA (1977). The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 15:29-35.
114. Ranasinghe AW, Johnson NW, Scragg MA, Williams RA (1989). Iron deficiency reduces cytochrome concentrations of mitochondria isolated from hamster cheek pouch epithelium. J Oral Pathol Med 18:582-585.
115. Reichart PA, Samaranayake LP, Philipsen HP (2000). Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Diseases 6:85-91.
116. Rennie JS, MacDonald DG, Dagg JH (1984). Iron and the oral epithelium: a review. J R Soc Med 77:602-607.
117. Renstrup G (1970). Occurrence of Candida in oral leukoplakia. Acta Pathol Microbiol Scand 78:421-424.
118. Robinson SS, Tasker S (1947). Chronic latent oral moniliasis (thrush): report a case of twelve years duration in which the disease was resistant to treatment. Arch Dermatol Syphilol 55:85-90.
119. Roed-Petersen B, Pindborg JJ (1973). A study of Danish snuffinduced oral leukoplakias. J Oral Pathol 2:301-313.
120. Roed-Petersen B, Renstrup G, Pindborg JJ (1970). Candida in oral leukoplakia. A histological and exfoliative cytologic study, Scand J Dent Res 78:323-328.
121. Ruechel R (1986). Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiolog Sci 3:316-319.
122. Ruechel R (1990). Virulence factors of Candida species. In: Oral candidosis. Chap. 4. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
123. Russell C, Jones JH (1975). The histology of prolonged candidal infection of the rat's tongue. J Oral Pathol 4:330-339.
124. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. (2001). Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 30:49-53.
125. Samaranayake LP (1986). Nutritional factors and oral candidosis. J Oral Pathol 15:61-65.
126. Samaranayake LP (1990). Host factors and oral candidosis. In: Oral candidosis. Chap. 5. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
127. Samaranayake LP (1991). Superficial fungal infections. In: Current opinions in dentistry. Scully C, editor. Philadelphia, PA: Current Science, pp. 415-422.
128. Samaranayake LP, Ellepola ANB (2000). Studying Candida albicans adhesion. In: Handbook of bacterial adhesion: principles, methods and applications. An Y, Friedman RJ, editors. New Jersey: Humana Press, pp. 527-540.
129. Samaranayake LP, MacFarlane TW (1982). Factors affecting the in-vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin. Arch Oral Biol 27:869-873.
130. Samaranayake LP, MacFarlane TW (1985). Hypothesis: on the role of dietary carbohydrates in the pathogenesis of oral candidosis. FEMS Microbiol Lett 527:1 5.
131. Samaranayake LP, MacFarlane TW, editors (1990). Oral candidosis. London: Butterworth.
132. Samaranayake LP, Geddes DAM, Weetman DA, MacFarlane TW (1983). Growth and acid production of Candida albicans in carbohydrated supplemented media. Microbios 37:105-115.
133. Samaranayake LP, Calman KC, Ferguson MM (1984a). The oral carriage of yeasts and coliforms in patients on cytotoxic therapy. J Oral Pathol 13:390-393.
134. Samaranayake LP, Hughes A, MacFarlane TW (1984b). The proteolytic potential of Candida albicans in human saliva supplemented with glucose. J Med Microbiol 17:13-22.
135. Samaranayake LP, Reaside J, MacFarlane TW (1984c). Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22:201-204.
136. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM (1986). A comparison of rinse culture and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 15:386-388.
137. Samaranayake LP, Robertson AG, MacFarlane TW (1988). The effect of chlorhexidine gluconate and benzylamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 39:291-294.
138. Samaranayake YH, Samaranayake LP (2001). Experimental oral candidiasis in animal models. Clin Microbiol Rev 14:398-429.
139. Schoelch ML, Sekandari N, Regezi JA, Silverman S Jr (1999). Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109:949-953.
140. Scully C, Cawson RA (2001). Medical problems in dentistry. Bristol: Wright.
141. Scully C, ElKabir M, Samaranayake LP (1994). Candida and oral candidosis: a review. Crit Rev Oral Biol Med 5:125-157.
142. Shakir BS, Martin MV, Smith CJ (1986). Epithelial mitotic activity during the induction of palatal candidosis in the Wistar rat. J Oral Pathol 15:375-380.
143. Shipman B (1979). Clinical evaluation of oral Candida in cancer chemotherapy patients. J Prosthet Dent 41:63-67.
144. Silverman S Jr, Migliorati J, Epstein L, Samaranayake LP (1990). Laboratory diagnosis of oral candidosis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
145. Slutsky B, Buffo J, Soll DR (1985). High frequency switching of colony morphology in Candida albicans. Science 230:666-669.
146. Sohnle PG, Kirkpatrick CH (1978). Epidermal proliferation in the defence against experimental cutaneous candidiasis. J Invest Dermatol 70:130-133.
147. Soll DR (2002). Phenotypic switching. In: Candida and candidiasis. Calderone RA, editor. Washington, DC: ASM Press, pp. 123-142.
148. Soll DR, Slutsky B, MacKenzie S, Langtimm C, Staebell M (1987). Switching systems in Candida albicans and their possible roles in oral candidiasis. In: Oral mucosal diseases: biology, etiology and therapy. Mackenzie IC, Squier CA, Dabelsteen E, editors. Denmark: Laegeforeningens-forlag, pp. 52-59.
149. Spector SL, Wangaard C, Bardana EJ (1982). The use of cultures and immunologic procedures to predict oropharyngeal candidiasis in patients on steroid aerosols. Clin Allergy 12:269-278.
150. Staib F (1965). Metabolism of human serum proteins by strains of Candida albicans and Cryptococcus neoformans. Mycopathol Mycol Appl 26:209-224.
151. Staib F (1969). Proteolysis and pathogenicity of Candida albicans strains. Mycopathol Mycolog Appl 37:345-348.
152. Tapper-Jones LM, Aldred MJ, Walker DM, Hayes TM (1981). Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 34:706-711.
153. Tronchin G, Bauchara JP, Robert R, Senet JM (1988). Adherence of Candida albicans germ tubes to plastic: ultrastructural and molecular studies of fibrillar adhesion. Infect Immun 56:1987-1993.
154. van Cutsem J, Thienpont D (1971). Experimental cutaneous Candida albicans infections in guinea-pigs. Sabouraudia 9:17-20.
155. Walker DM, Arendorf TM (1990). Candidal leukoplakia. Chronic multifocal candidosis and median rhomboid glossitis. In: Oral candidosis. Chap. 10. Samaranayake LP, MacFarlane TW, editors. London: Butterworth.
156. Warnakulasuriya S (2000). Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190:407-409.
157. Werner H (1966). Untersuchungen über die Lipaseaktivität bei Hefen und hefeahnlichen Pilzen. Zentralblatt für Bakteriologie und Hygiene I. Abt Orig 200:113-124.
158. WHO Collaborating Reference Centre for Oral Precancerous Lesions (1978). Definition of leukoplakia and related lesions; an aid to studies on oral pre-cancer. Oral Surg Oral Med Oral Pathol 46:517-539.
159. Williams DM (1969). Chronic hyperplastic candidiasis and squamous carcinoma. Br J Dermatol 81:125-127.
160. Williams DW, Lewis MAO (2000). Isolation and identification of candida from oral cavity. Oral Dis 6:3-11.
161. Williams DW, Wilson MJ, Lewis MAO (1995). Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol 33:2476-2479.
162. Williams DW, Wilson MJ, Lewis MAO (1996). Identification of Candida species in formalin fixed, paraffin wax embedded oral mucosal by sequencing of ribosomal DNA. J Clin Pathol Mol Pathol 49:M23-M28.
163. Williams DW, Potts AJ, Wilson MJ, Matthews JB, Lewis MA (1997). Characterisation of the inflammatory cell infiltrate in chronic hyperplastic candidosis of the oral mucosa (abstract). J Dent Res 75:1144.
164. Williams DW, Jones HS, Allison RT, Potts AJ, Lewis MA (1998). Immunocytochemical detection of Candida albicans in formalin fixed, paraffin embedded material. J Clin Pathol 51:857-859.
165. Williams DW, Wilson MJ, Potts AJ, Lewis MA (2000). Phenotypic characterisation of Candida albicans isolated from chronic hyperplastic candidosis. J Med Microbiol 49:199-202.
166. Williamson DM (1969). Chronic hyperplastic candidiasis and squamous carcinoma. Br J Dermatol 81:125-127.
167. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ (1999). Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16:675-679.
168. Wilson RM, Reeves WG (1986). Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 63:478-484.
169. Wilton JM, Lehner T (1981). Immunology of candidiasis. In: Immunology of human infection. Nahmias EJ, O'Reilly RJ, editors. New York: Plenum Medical, pp. 525-559.
170. Winner HI (1955). A study of Candida albicans agglutinins in human sera. J Hygiene 53:509-512.
171. World Health Organization (1997). Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Pindborg JJ, Reichart PA, Smith CJ, van der Wall I, editors. Berlin: Springer-Verlag, pp. 21-31.
172. Zasloff M (1992). Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 4:3-7.
173. Zhang KH, Wang HJ, Qin JX (1994). Effect of candidal infection on the hyperplastic oral epithelium. Zhonghua Kou Qiang Yi Xue Za Zhi 29:339-341.
174. Zimmermann CF (1986). Immunohistochemischer Nachweis von candida Protease bei verschiedenen Manifestationen der Candida-Mykose (DDS Thesis). Göttingen, Germany: Faculty of Medicine, University of Göttingen.
175. Zimmermann E, Zimmermann A (1965). Effect of race, age, smoking habits and oral systemic disease on oral exfoliative cytology. J Dent Res 44:627-631.